540 related articles for article (PubMed ID: 24853416)
1. Integrated analyses identify the involvement of microRNA-26a in epithelial-mesenchymal transition during idiopathic pulmonary fibrosis.
Liang H; Gu Y; Li T; Zhang Y; Huangfu L; Hu M; Zhao D; Chen Y; Liu S; Dong Y; Li X; Lu Y; Yang B; Shan H
Cell Death Dis; 2014 May; 5(5):e1238. PubMed ID: 24853416
[TBL] [Abstract][Full Text] [Related]
2. miR-26a suppresses EMT by disrupting the Lin28B/let-7d axis: potential cross-talks among miRNAs in IPF.
Liang H; Liu S; Chen Y; Bai X; Liu L; Dong Y; Hu M; Su X; Chen Y; Huangfu L; Li X; Gu Y; Shan H
J Mol Med (Berl); 2016 Jun; 94(6):655-65. PubMed ID: 26787543
[TBL] [Abstract][Full Text] [Related]
3. Silencing lncRNA Snhg6 mitigates bleomycin-induced pulmonary fibrosis in mice via miR-26a-5p/TGF-β1-smads axis.
Deng W; Zhang Y; Fang P; Shi H; Yang S
Environ Toxicol; 2022 Oct; 37(10):2375-2387. PubMed ID: 35785413
[TBL] [Abstract][Full Text] [Related]
4. miR‑221 targets HMGA2 to inhibit bleomycin‑induced pulmonary fibrosis by regulating TGF‑β1/Smad3-induced EMT.
Wang YC; Liu JS; Tang HK; Nie J; Zhu JX; Wen LL; Guo QL
Int J Mol Med; 2016 Oct; 38(4):1208-16. PubMed ID: 27513632
[TBL] [Abstract][Full Text] [Related]
5. The antifibrotic effects and mechanisms of microRNA-26a action in idiopathic pulmonary fibrosis.
Liang H; Xu C; Pan Z; Zhang Y; Xu Z; Chen Y; Li T; Li X; Liu Y; Huangfu L; Lu Y; Zhang Z; Yang B; Gitau S; Lu Y; Shan H; Du Z
Mol Ther; 2014 Jun; 22(6):1122-1133. PubMed ID: 24594795
[TBL] [Abstract][Full Text] [Related]
6. MiR-326-mediated overexpression of NFIB offsets TGF-β induced epithelial to mesenchymal transition and reverses lung fibrosis.
Pattnaik B; Negi V; Chaudhuri R; Desiraju K; Faizan MI; Akhtar A; Ansari MS; Shakir M; Gheware A; Prakash YS; Guleria R; Ghosh B; Agrawal A; Ahmad T
Cell Mol Life Sci; 2023 Nov; 80(12):357. PubMed ID: 37950757
[TBL] [Abstract][Full Text] [Related]
7. Transforming growth factor (TGF)-β1-induced miR-133a inhibits myofibroblast differentiation and pulmonary fibrosis.
Wei P; Xie Y; Abel PW; Huang Y; Ma Q; Li L; Hao J; Wolff DW; Wei T; Tu Y
Cell Death Dis; 2019 Sep; 10(9):670. PubMed ID: 31511493
[TBL] [Abstract][Full Text] [Related]
8. miR-18a-5p Inhibits Sub-pleural Pulmonary Fibrosis by Targeting TGF-β Receptor II.
Zhang Q; Ye H; Xiang F; Song LJ; Zhou LL; Cai PC; Zhang JC; Yu F; Shi HZ; Su Y; Xin JB; Ma WL
Mol Ther; 2017 Mar; 25(3):728-738. PubMed ID: 28131417
[TBL] [Abstract][Full Text] [Related]
9. MicroRNAs in idiopathic pulmonary fibrosis.
Pandit KV; Milosevic J; Kaminski N
Transl Res; 2011 Apr; 157(4):191-9. PubMed ID: 21420029
[TBL] [Abstract][Full Text] [Related]
10. miR-21 mediates fibrogenic activation of pulmonary fibroblasts and lung fibrosis.
Liu G; Friggeri A; Yang Y; Milosevic J; Ding Q; Thannickal VJ; Kaminski N; Abraham E
J Exp Med; 2010 Aug; 207(8):1589-97. PubMed ID: 20643828
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of lncRNA PFRL prevents pulmonary fibrosis by disrupting the miR-26a/smad2 loop.
Jiang H; Chen Y; Yu T; Zhao X; Shan H; Sun J; Zhang L; Li X; Shan H; Liang H
Am J Physiol Lung Cell Mol Physiol; 2018 Oct; 315(4):L563-L575. PubMed ID: 29952219
[TBL] [Abstract][Full Text] [Related]
12. YAP1/Twist promotes fibroblast activation and lung fibrosis that conferred by miR-15a loss in IPF.
Chen Y; Zhao X; Sun J; Su W; Zhang L; Li Y; Liu Y; Zhang L; Lu Y; Shan H; Liang H
Cell Death Differ; 2019 Sep; 26(9):1832-1844. PubMed ID: 30644438
[TBL] [Abstract][Full Text] [Related]
13. Osteopontin silencing attenuates bleomycin-induced murine pulmonary fibrosis by regulating epithelial-mesenchymal transition.
Hatipoglu OF; Uctepe E; Opoku G; Wake H; Ikemura K; Ohtsuki T; Inagaki J; Gunduz M; Gunduz E; Watanabe S; Nishinaka T; Takahashi H; Hirohata S
Biomed Pharmacother; 2021 Jul; 139():111633. PubMed ID: 34243624
[TBL] [Abstract][Full Text] [Related]
14. miR-184 targets TP63 to block idiopathic pulmonary fibrosis by inhibiting proliferation and epithelial-mesenchymal transition of airway epithelial cells.
Li J; Pan C; Tang C; Tan W; Zhang W; Guan J
Lab Invest; 2021 Feb; 101(2):142-154. PubMed ID: 32989231
[TBL] [Abstract][Full Text] [Related]
15. The MIR100HG/miR-29a-3p/Tab1 axis modulates TGF-β1-induced fibrotic changes in type II alveolar epithelial cells BLM-caused lung fibrogenesis in mice.
Guan S; Liu H; Zhou J; Zhang Q; Bi H
Toxicol Lett; 2022 Jun; 363():45-54. PubMed ID: 35472619
[TBL] [Abstract][Full Text] [Related]
16. Lung myofibroblasts are characterized by down-regulated cyclooxygenase-2 and its main metabolite, prostaglandin E2.
Gabasa M; Royo D; Molina-Molina M; Roca-Ferrer J; Pujols L; Picado C; Xaubet A; Pereda J
PLoS One; 2013; 8(6):e65445. PubMed ID: 23755232
[TBL] [Abstract][Full Text] [Related]
17. Bleomycin induces epithelial-to-mesenchymal transition via bFGF/PI3K/ESRP1 signaling in pulmonary fibrosis.
Weng CM; Li Q; Chen KJ; Xu CX; Deng MS; Li T; Zhang DD; Duan ZX; Chen ZQ; Li GH; Chen J; Wang JM
Biosci Rep; 2020 Jan; 40(1):. PubMed ID: 31868203
[TBL] [Abstract][Full Text] [Related]
18. Loss of Family with Sequence Similarity 13, Member A Exacerbates Pulmonary Fibrosis Potentially by Promoting Epithelial to Mesenchymal Transition.
Rahardini EP; Ikeda K; Nugroho DB; Hirata KI; Emoto N
Kobe J Med Sci; 2020 Jan; 65(3):E100-E109. PubMed ID: 32029695
[TBL] [Abstract][Full Text] [Related]
19. Deficiency of HtrA3 Attenuates Bleomycin-Induced Pulmonary Fibrosis Via TGF-β1/Smad Signaling Pathway.
Li G; Shen C; Wei D; Yang X; Jiang C; Yang X; Mao W; Zou J; Tan J; Chen J
Lung; 2023 Apr; 201(2):235-242. PubMed ID: 36823409
[TBL] [Abstract][Full Text] [Related]
20. Astragaloside IV modulates TGF-β1-dependent epithelial-mesenchymal transition in bleomycin-induced pulmonary fibrosis.
Qian W; Cai X; Qian Q; Zhang W; Wang D
J Cell Mol Med; 2018 Sep; 22(9):4354-4365. PubMed ID: 29971947
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]